Trial intelligence / Profile preview

Prevalence of Silent Myocardial Scars Following COVID-19

NCT04636320Completed

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Jun 2020
Primary completion
Apr 2022
Countries
1
01

Overview

Open-label trial (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Prevalence of myocardial scars at Day 0. Started Jun 2020; status: completed.

Beyond the preview

Go deeper on NCT04636320.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04636320.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call